pipoda 100mg/25mg tableta
orion corporation, espoo array - 1645 levodopa; 12698 monohydrÁt karbidopy - tableta - 100mg/25mg - levodopa a inhibitor dekarboxylasy
scandonest 30mg/ml injekční roztok
septodont ou septodont sas ou specialites septodont, saint-maur-des-fosses array - 904 mepivakain-hydrochlorid - injekční roztok - 30mg/ml - mepivakain
levobupivacaine kabi 5mg/ml injekční/infuzní roztok
fresenius kabi s.r.o., praha array - 12457 levobupivakain-hydrochlorid - injekční/infuzní roztok - 5mg/ml - levobupivakain
duodopa 20mg/ml+5mg/ml intestinální gel
abbvie s.r.o., praha array - 1645 levodopa; 2095 karbidopa - intestinální gel - 20mg/ml+5mg/ml - levodopa a inhibitor dekarboxylasy
lecigimon 20mg/ml+5mg/ml+20mg/ml intestinální gel
lobsor pharmaceuticals ab, uppsala array - 1645 levodopa; 12698 monohydrÁt karbidopy; 11197 entakapon - intestinální gel - 20mg/ml+5mg/ml+20mg/ml - levodopa, inhibitor dekarboxylasy a inhibitor comt
reparil n 10mg/g+50mg/g gel
viatris healthcare limited, dublin array - 554 escin; 482 diethylamin-salicylÁt - gel - 10mg/g+50mg/g - jinÁ lokÁlnÍ lÉČiva k terapii bolestÍ svalŮ a kloubŮ
sogroya
novo nordisk a/s - somapacitan - růst - hypofýzy a hypotalamické hormony a analogy - sogroya is indicated for the replacement of endogenous growth hormone (gh) in children aged 3 years and above, and adolescents with growth failure due to growth hormone deficiency (paediatric ghd), and in adults with growth hormone deficiency (adult ghd).
tavneos
vifor fresenius medical care renal pharma france - avacopan - microscopic polyangiitis; wegener granulomatosis - imunosupresiva - tavneos, in combination with a rituximab or cyclophosphamide regimen, is indicated for the treatment of adult patients with severe, active granulomatosis with polyangiitis (gpa) or microscopic polyangiitis (mpa).
zokinvy
eigerbio europe limited - lonafarnib - progeria; laminopathies - jiné zažívací trakt a produkty metabolismu, - zokinvy is indicated for the treatment of patients 12 months of age and older with a genetically confirmed diagnosis of hutchinson-gilford progeria syndrome or a processing-deficient progeroid laminopathy associated with either a heterozygous lmna mutation with progerin-like protein accumulation or a homozygous or compound heterozygous zmpste24 mutation.
axia daily 0,02mg/3mg potahovaná tableta
adamed pharma s.a., czosnów array - 578 ethinylestradiol; 11275 drospirenon - potahovaná tableta - 0,02mg/3mg - drospirenon a ethinylestradiol